Stock News

Bristol-Myers Pushes Celgene Deal, Starboard Hits Back, in $74B Takeover Spat
Jim Cramer Breaks Down Tilray Earnings, Elon Musk's Twitter and Bristol-Myers
Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene
U.S. FDA approves Roche's small cell lung cancer treatment

As seen on...